Exposure work-ups often involve tracing the movement of the patient and identifying staff who might have been exposed. But with COVID-19 is that feasible?
Infection preventionists (IPs) and other healthcare workers exposed to COVID-19 should be monitored like they've been exposed to tuberculosis or meningitis, according to the US Centers for Disease Control and Prevention (CDC), but the difficult-to-pin-down epidemiological nature of COVID-19 and its quick spread presents hurdles for doing so. Since exposure reviews can be quite time intensive, they will require a collaborative effort with leadership and staff, and if possible, perhaps a light-duty healthcare worker can assist in the identification and notification of staff. Such efforts are critical though, to help reduce the spread of transmission not only in the community, but also in healthcare.
Risk categories can be found here, and ultimately note that staff with prolonged contact (exposure greater than a few minutes) in which no personal protective equipment (PPE) was worn should be actively monitored. Not only that, but they shouldn’t work for the 14 day-incubation period after the last known date of exposure.
Exposure work-ups often involve tracing the movement of the patient and identifying staff who might have been exposed. Quick response is key, as often there’s a short window of opportunity in which to perform prophylaxis for healthcare workers who’ve been exposed.It’s important to determine which staff meet that higher risk category due to a lack of PPE and prolonged, close contact with a COVID-19 patient.
Now is likely the time for infection prevention programs to establish a process. Perhaps a larger notification process with generalized verbiage notifying those staff in the areas of care (or interaction with the patient) that a positive patient was identified and to report any signs of illness within 14 days? What about quarantine for those staff who had a high-risk exposure, such as unprotected for an extended period of time? The CDC defines close contact for “healthcare exposures as:
· Being within approximately 6 feet (2 meters) of a person with COVID-19 for a prolonged period of time (such as caring for, or visiting, the patient; or sitting within 6 feet of the patient in a healthcare waiting area or room).
· Having unprotected direct contact with infectious secretions or excretions of the patient (e.g., being coughed on, touching used tissues with a bare hand).Moreover, it is important to define exposure risk to determine if staff will be required to quarantine at home for the incubation period.
Guidance from many health departments has stated that COVID-19 exposures may no longer need review as cases increase and the burden becomes too much. The thought is that healthcare workers will increasingly have the potential for community exposure and general risk is now anticipated. This is challenging though, as the ethical aspects of infection prevention push us to notify staff and ensure they are aware of any potential exposure, even if low risk.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.